Dan Kidle - Profile and Investment Details

Investor Profile

Dan Kidle is a Venture Capital, Private Equity Firm, Investor based in Ann Arbor, Michigan, United States with a diverse investment portfolio that includes companies such as Inogen, Cardiac Dimensions, Akadeum Life Sciences, Inc., Aira, Strata Oncology, Esperion Therapeutics, Concerto Healthcare, Tangent Medical Technologies, Asterand, Rethink First, DropWorks, Inc., SI-BONE, Flosonics Medical, Koya Medical, Jumpcode Genomics, NxTheraAccuri Cytometers, HandyLab, Swift Biosciences, Advance Medical, Mirabilis Medical, Swift Biosciences, Inc, NeuMoDx Molecular, Fifth Eye, Wellfount, Flosonics, BrightSpec, Inc., nVision Medical, Fidelis SeniorCare, Pear Therapeutics, Enumera Molecular, Health Scholars, SonarMD, EQRx, Delphinus Medical Technologies, Uptake Medical, BAROnova, ArborMetrix, Francis Medical, CardioMEMS, KFx Medical, PAK BioSolutions, My Health Direct, Sonitus Medical, Intellicyt, Ebb Therapeutics, BioIQ, Cervilenz, NeoGuide Systems, PathCentral, Adavium, Hicuity Health, Inc., Lucina Health, . Over time, Dan Kidle has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Dan Kidle is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Women Founded, Life Science, Portfolio Management, Analytics, Software, Biotechnology, Medical Devices, Clinical Trials, Consumer Internet, Digital Health, Medical, SaaS, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Diverse Founder Investments, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Dan Kidle, as their portfolio suggests a familiarity and interest in this area.

Understanding Dan Kidle’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.